• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Message on the passing of Dr Mwele Ntuli Malecela from DNDi Executive Director Dr Bernard Pécoul

11 Feb 2022

It is with profound sadness that we learned of the passing of Dr Mwele Ntuli Malecela, an unshakable champion of communities affected by neglected tropical diseases (NTDs) around the world. We join today with countless clinicians, scientists, advocates, and friends in mourning the loss of a visionary leader whose passion and commitment have inspired and empowered so many.

From her early career advancing research for lymphatic filariasis to her transformational leadership of the WHO Department of Neglected Tropical Diseases, Dr Mwele used her tremendous skills to bring the health needs of neglected patients to the forefront of the global health agenda. She made plain that the struggle against neglected tropical diseases is so much more than a fight against parasites and infections – that it is first and foremost a fight for human dignity and for the health and security of vulnerable and marginalized people.

Dr Mwele was a trusted advisor and friend to so many of our colleagues and partners. Early in her tenure as WHO NTD Director, she visited our offices to introduce her vision for progress toward NTD control and elimination – a vision that was instrumental in guiding the development of the WHO 2021-2030 Roadmap for NTDs.

Dr Nathalie Strub-Wourgaft, DNDi COVID-19 Response and Pandemic Preparedness Director and former DNDi Director of Neglected Tropical Diseases remembers Dr Mwele for ‘bringing something unique and very critical to the picture. She knew that how we look at NTDs needed to be about their impact on people’s lives: what losing a mother means to a young child’s future, what disability means to a father who is unable to provide for his family. She put stigma – and the impact of NTDs on mental health – on the table. And in so many ways, she brought the logic and the strategic vision, including by championing the need for innovation in diagnostic tools as a critical enabler of the test-and-treat strategies we need to employ to save lives and reach our goals for control and elimination.’

Dr Mwele shined as a bright mind and savvy negotiator, but also someone who always showed the way with humility and kindness.

Dr Monique Wasunna, DNDi Africa Regional Officer, first met Dr Mwele at a scientific conference in Uganda, early in their careers in the 90’s. ‘I knew that Mwele was someone very special right from the beginning. She had such a keen intellect and was also so kind, such a beautiful soul. Mwele’s impact throughout her career came from a very pure desire to improve people’s lives. She accompanied DNDi in our evolution as an organization and we owe her a tremendous debt as an ally and a friend. She was a fighter, and she set such an amazing example for our daughters to look up to. In the Roadmap she worked so tirelessly to foster and support, we have a clear path to reducing suffering and building prosperity in communities affected by NTDs. It has been such a privilege to know Mwele as a both a colleague and dear friend. We will carry on her fight.’

Our teams will continue to be inspired by Dr Mwele’s indelible legacy of compassion and commitment. We express our deepest condolences to her family, colleagues, and friends.

Read, watch, share

Loading...
Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Two man outside of a hospital talking with a nurse
Press releases
24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

Woman walking in a laboratory
Press releases
23 Apr 2025

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Stories
16 Apr 2025

Drug discovery explained: Chagas – How to prove treatments work?

Statements
16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Press releases
15 Apr 2025

New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License